AFT Pharmaceuticals Limited (ASX: AFP)
Australia
· Delayed Price · Currency is AUD 2.550
0.00 (0.00%)
Dec 20, 2024, 11:29 AM AEST
AFT Pharmaceuticals Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 11.61 | 15.61 | 10.65 | 19.85 | 7.78 | 12.69 | Upgrade
|
| Depreciation & Amortization | 1.49 | 1.2 | 0.85 | 0.91 | 0.98 | 0.96 | Upgrade
|
| Other Amortization | 0.81 | 0.81 | 0.88 | 0.13 | 0.13 | 0.14 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.57 | 0.57 | 0.53 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -9.78 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | - | 0.08 | Upgrade
|
| Stock-Based Compensation | 0.2 | 0.14 | - | 0.01 | 0.04 | 0.11 | Upgrade
|
| Other Operating Activities | 8.1 | 9.03 | 5.67 | 0.72 | 3.46 | 9.67 | Upgrade
|
| Change in Accounts Receivable | 5.41 | 2.5 | -10.72 | -4.96 | -4.56 | -7.3 | Upgrade
|
| Change in Inventory | 6.77 | -6.66 | -8.9 | 0.15 | -10.92 | 2.43 | Upgrade
|
| Change in Accounts Payable | -9.22 | 5.67 | 12.67 | -2.66 | 3.84 | 5.88 | Upgrade
|
| Operating Cash Flow | 25.75 | 28.86 | 11.63 | 14.15 | 0.75 | 14.88 | Upgrade
|
| Operating Cash Flow Growth | 96.31% | 148.18% | -17.83% | 1786.93% | -94.96% | 1294.38% | Upgrade
|
| Capital Expenditures | -0.19 | -0.12 | -0.2 | -0.33 | -0.09 | -0.09 | Upgrade
|
| Sale (Purchase) of Intangibles | -8.43 | -9.41 | -8.98 | -5.26 | -6.14 | -6.47 | Upgrade
|
| Investing Cash Flow | -8.62 | -9.53 | -9.18 | -5.59 | -6.23 | -6.56 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 1.64 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 5 | - | 58.2 | Upgrade
|
| Total Debt Issued | 1.84 | - | - | 5 | 1.64 | 58.2 | Upgrade
|
| Long-Term Debt Repaid | - | -5.86 | -4.59 | -5.38 | -7.13 | -60.86 | Upgrade
|
| Net Debt Issued (Repaid) | -4.1 | -5.86 | -4.59 | -0.38 | -5.49 | -2.66 | Upgrade
|
| Issuance of Common Stock | - | - | 0.48 | 0.3 | 12.4 | 0 | Upgrade
|
| Preferred Dividends Paid | - | - | - | - | -0.19 | - | Upgrade
|
| Common Dividends Paid | -1.68 | -1.15 | - | - | - | - | Upgrade
|
| Dividends Paid | -1.68 | -1.15 | - | - | -0.19 | -0.57 | Upgrade
|
| Other Financing Activities | -3.17 | -3.62 | -2.86 | -2.19 | -4.19 | -5.9 | Upgrade
|
| Financing Cash Flow | -8.95 | -10.63 | -6.98 | -2.28 | 2.52 | -9.12 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.08 | 0.05 | -0.12 | 0.1 | 0.05 | 0.01 | Upgrade
|
| Net Cash Flow | 8.1 | 8.75 | -4.65 | 6.39 | -2.91 | -0.8 | Upgrade
|
| Free Cash Flow | 25.56 | 28.75 | 11.43 | 13.82 | 0.66 | 14.79 | Upgrade
|
| Free Cash Flow Growth | 97.24% | 151.44% | -17.30% | 2003.96% | -95.56% | 1495.04% | Upgrade
|
| Free Cash Flow Margin | 12.87% | 14.71% | 7.30% | 10.61% | 0.58% | 14.00% | Upgrade
|
| Free Cash Flow Per Share | 0.22 | 0.27 | 0.11 | 0.13 | 0.01 | 0.15 | Upgrade
|
| Cash Interest Paid | 3.23 | 3.69 | 2.87 | 2.2 | 3.48 | 5.9 | Upgrade
|
| Cash Income Tax Paid | 1.32 | 1.22 | 1.34 | 0.22 | 0.17 | 0.22 | Upgrade
|
| Levered Free Cash Flow | 3.43 | 10.16 | -4.97 | -0.03 | -12.29 | -1.54 | Upgrade
|
| Unlevered Free Cash Flow | 5.45 | 12.46 | -3.17 | 1.49 | -10.14 | 2.81 | Upgrade
|
| Change in Net Working Capital | 0.43 | -4.69 | 8.01 | 6.73 | 11.75 | -0.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.